Thomas M.
Hood
and
Adrian B.
Chaplin
*
Department of Chemistry, University of Warwick, Gibbet Hill Road, Coventry CV4 7AL, UK. E-mail: a.b.chaplin@warwick.ac.uk
First published on 20th January 2021
Having recently reported on the synthesis and rhodium complexes of the novel macrocyclic pincer ligand PNP-14, which is derived from lutidine and features terminal phosphine donors trans-substituted with a tetradecamethylene linker (Dalton Trans., 2020, 49, 2077–2086 and Dalton Trans., 2020, 49, 16649–16652), we herein describe our findings critically examining the chemistry of iridium homologues. The five-coordinate iridium(I) and iridium(III) complexes [Ir(PNP-14)(η2:η2-cyclooctadiene)][BArF4] and [Ir(PNP-14)(2,2′-biphenyl)][BArF4] are readily prepared and shown to be effective precursors for the generation of iridium(III) dihydride dihydrogen, iridium(I) bis(ethylene), and iridium(I) carbonyl derivatives that highlight important periodic trends by comparison to rhodium counterparts. Reaction of [Ir(PNP-14)H2(H2)][BArF4] with 3,3-dimethylbutene induced triple C–H bond activation of the methylene chain, yielding an iridium(III) allyl hydride derivative [Ir(PNP-14*)H][BArF4], whilst catalytic homocoupling of 3,3-dimethylbutyne into Z-tBuCCCHCHtBu could be promoted at RT by [Ir(PNP-14)(η2:η2-cyclooctadiene)][BArF4] (TOFinitial = 28 h−1). The mechanism of the latter is proposed to involve formation and direct reaction of a vinylidene derivative with HCCtBu outside of the macrocyclic ring and this suggestion is supported experimentally by isolation and crystallographic characterisation of a catalyst deactivation product.
Motivated by the potential to exploit additional reaction control though their unique steric profile, use in the construction of interlocked assemblies, and as an extension of our related work with NHC-based variants,11–13 we have recently become interested in the chemistry of macrocyclic phosphine-based pincers.14–16 Last year we reported on the synthesis and rhodium complexes of the lutidine-derived macrocyclic pincer PNP-14, where the chiral P-donors are trans-substituted with a tetradecamethylene linker (Chart 1).14,15 As a novel platform for exploring the organometallic chemistry of Group 9 pincer complexes, we now present our findings critically examining the chemistry of iridium PNP-14 homologues aided by reference to acyclic complexes of 2,6-(R2PCH2)2C5H3N (PNP-R; e.g. R = tBu, iPr).
Iridium(I) complex 1 adopts a distorted trigonal bipyramidal metal geometry (18 VE), with the terminal phosphine donors positioned in the equatorial coordination sites conferring a distinctly puckered pincer ligand geometry. Distortion of the PNP ligand towards a fac coordination mode in this manner is associated with a compressed P–Ir–P bite angle of 115.24(2)° in the solid state and a pair of 31P resonances at δ 17.0 and 13.4 with no appreciable 2JPP coupling in DFB solution. While unusual, the formulation of 1 simply appears to be a consequence of COD chelation, although this is contingent upon the flexible lutidine-based backbone and asymmetric steric profile of the phosphine donors.19 Moreover, given the rhodium(I) homologue is instead characterised as a C1-symmetric square planar complex, viz. [Rh(PNP-14)(η2-COD)]+(1′, 16 VE; δ31P 57.4, 45.9, 2JPP = 312 Hz),15,20 the capacity of the heavier metal congener to from stronger metal–ligand bonds is clearly a decisive factor. Bulk purity was established by combustion analysis and the structure of 1 was fully corroborated in solution by NMR spectroscopy and HR ESI-MS.
Coordination of PNP-14 is more conventional in the formally 16 VE square pyramidal iridium(III) complex 2, as evidenced by a P–Ir–P bite angle of 163.24(5)° in the solid state and C1 symmetry in CD2Cl2 solution; with a pair of 31P resonances at δ 38.7 and 20.9 exhibiting a characteristically large trans-phosphine 2JPP coupling constant of 307 Hz.21 The crystal structure of 2 is isomorphous to the direct rhodium homologue 2′,14 with the tetradecamethylene linker skewed to one side of the basal plane away from the biph ligand and contorted in such a way as to enable adoption of a weak γ-agostic interaction (2, ⋯H– = 3.152(7); cf. 3.184(2) Å for 2′). Previously reported five-coordinate complexes of the form [M(pincer)(biph)][BArF4] provide further structural precedent for 2 and the metal-based metrics of the acyclic analogue [Ir(PNP-tBu)(biph)][BArF4] (II) are similar.6,11,14 Moreover, as II is fluxional in solution as a result of facile biph pseudorotation on the NMR timescale,6 retention of C1 symmetry in solution suggests that buttressing with the methylene strap prevents such dynamics in 2.
Reaction of 2 with dihydrogen (1 atm) in DFB at RT resulted in immediate and full conversion into [Ir(PNP-14)(2-biphenyl)H][BArF4] 3 (δ31P 40.6, 36.5, 2JPP = 302 Hz; δ1H −21.6; Scheme 2). No further reaction was observed after 18 h, but heating at 85 °C for 6 h resulted in complete hydrogenolysis of the biph ligand and formation of dihydride dihydrogen complex [Ir(PNP-14)H2(H2)][BArF4] 4 in quantitative spectroscopic yield. Hydrogenolysis also occurs for 2′ and II, but longer reaction times are required under otherwise equivalent conditions (both ca. 2 days).14 Coordinatively saturated 1 rapidly affords 4 upon reaction with dihydrogen (1 atm) in DFB at RT (<5 min), invoking facile and reversible chelation of COD.
Scheme 2 Synthesis and reactivity of iridium dihydride dihydrogen complex 4. [BArF4]− counter anions omitted for clarity. |
Complex 4 was characterised in situ using NMR spectroscopy, with adoption of time-averaged C2 symmetry, a single 31P resonance at δ 42.1, and a broad 4H resonance at δ −9.26 (T1 = 88.8 ± 0.7 ms, 600 MHz, argon) the most diagnostic features at 298 K. The hydride signal remained broad upon cooling to 253 K but exhibits faster spin–lattice relaxation (δ −9.27, T1 = 50 ± 1 ms, 600 MHz, argon). The acyclic analogue [Ir(PNP-tBu)H2(H2)]BF4 (IV) is known and formulation as a dihydride dihydrogen complex was corroborated in a similar manner in situ by NMR spectroscopy.7 Whilst the data was recorded under difference conditions, the similarly of the hydride signatures is striking (IV, δ1H −9.31, T1 = 24 ms, 400 MHz, 233 K in CD3OD). In line with the reduced propensity for oxidative addition, the rhodium homologue of 4 is instead observed as a dihydrogen complex, viz. [Rh(PNP-14)(H2)][BArF4] 4′.14
Further supporting the assignment of 4, reaction with ethylene (1 atm) generated the corresponding C1-symmetric dihydride π-complex 5 (δ31P 33.4, 12.4, 2JPP = 314; δ1H −7.89, −17.80) within 5 min at RT (Scheme 2). Subsequent heating at 85 °C for 16 h yielded the bis(ethylene) complex 6 (δ31P 9.0) in quantitative spectroscopic yield, with concomitant formation of ethane. C2 symmetry and coordination of two molecules of ethylene was established in situ by NMR spectroscopy. The latter is associated with four chemically inequivalent 2H signals at δ 3.23, 2.80, 2.49 and 1.97 and two 13C resonances at δ 26.0 and 18.0, and reinforces the disposition of iridium(I) centres to adopt five-coordinate geometries: as seen in 2, but contrasting that observed under the same conditions in the rhodium(I) system, viz. [Rh(PNP-14)(C2H4)][BArF4] 6′.14 Structurally-related bis(ethylene) iridium(I) complexes of CNC- and pybox-based pincer ligands have been crystallographically characterised, exhibiting distorted trigonal bipyramidal metal geometries with the ethylene ligands located in the equatorial sites,22 but are unknown for PNP- and PONOP-based ligands.23
When 2 was instead treated with an excess of 3,3-dimethylbutene (5 equivalents) the allyl hydride derivative [Ir(PNP-14*)H][BArF4] 7 was produced in quantitative spectroscopic yield after 5 days heating at 100 °C, presumably through intramolecular transfer dehydrogenation of the methylene chain followed by allylic C–H activation (Scheme 2).24 As precedent for this reactivity, examples of cyclometallated rhodium(III) and iridium(III) pincer complexes can be found in the literature.25 Complex 7 was subsequentially isolated in 49% yield and fully characterised, including in the solid state by single crystal X-ray diffraction (Fig. 1). In solution 7 is distinctly C1-symmetric, with a pair of 31P resonances at δ 81.4 and 25.8 with 2JPP = 313 Hz, allyl 13C resonances at δ 81.9, 66.0, and 38.9, and a 1H hydride resonance at δ −8.49 (2JPH = 19.6, 9.7 Hz). The crystal structure demonstrates that 7 adopts a pseudo-octahedral metal geometry in the solid state, with κ6-coordination of PNP-14* creating iridacyclopentyl and iridacyclododecyl rings, and the hydride ligand was located from the Fourier difference map. Little distortion of the PNP-core is evident in 7 and the associated metal-based metrics are broadly comparable to those in 2 (e.g. P–Ir–P ca. 163°). There is considerable variance in the allyl Ir–C bond lengths, with the longest contact trans to the hydride ligand (Ir1–C119 = 2.311(4) Å, Ir1–C120, 2.155(3) Å, Ir1–C121, 2.199(3) Å), but all the internal carbon bond angles are >120°. The geometry of the iridacyclododecyl ring is reminiscent of the quadrilateral conformations adopted by 12-membered cycloalkanes.26
The onward reactivity of 6 was harnessed to access the C2-symmetric Ir(I) carbonyl derivative 8 (δ31P 62.5) by reaction with carbon monoxide, which was isolated in 89% yield (overall from 2; Scheme 2). Complexes of this nature are of interest as the carbonyl ligand is a convenient spectroscopic reporter group for the electronic characteristics of the metal-pincer fragment.27,28 In this case, the ν(CO) band of 8 (1984 cm−1) is shifted to considerably lower frequency compared to the rhodium(I) homologue 8′ (1997 cm−1) under the same conditions (CH2Cl2 solution, Table 1). This is in line with expected periodic trends, which are also apparent from the IR data collected for tBu- and iPr-substituted analogues. These data suggest that PNP-14 is a marginally weaker net donor than PNP-tBu, but equivalent to PNP-iPr.14
Of the organometallic chemistry we have discovered so far using PNP-14, the capacity for rhodium complexes to promote the stoichiometric homocoupling of 3,3-dimethylbutyne through the annulus of the macrocyclic ligand stands out (1′ → 9′ in Scheme 3).15 Given that a structurally related Ir(PCP) system has also been shown to promote stoichiometric terminal alkyne coupling reactions,30,31 we were very interested to ascertain if similar reactivity could be brought about in iridium complexes of PNP-14. Iridium(I) complex 1 was selected as the most suitable precursor and initial screening studies using a twofold excess of HCCtBu in DFB at RT indicated rapid production of the corresponding Z-enyne (δ1H 5.53, 5.25; 3JHH = 11.9 Hz)32 without any observable consumption of 1 (Scheme 3). This stereochemistry contrasts that observed for the rhodium system and, as homocoupling through the macrocycle would be expected to result in an interpenetrated enyne complex, it appears that production of the enyne occurs catalytically outside the ring. Subsequent detailed investigation of this reaction using 100 equivalents HCCtBu confirmed that 1 is an effective precatalyst.33 Under these conditions, the dimerisation of HCCtBu into Z-tBuCCCHCHtBu proceeds with an initial TOF of 28 h−1. After 6 h, analysis by 1H NMR spectroscopy indicated complete consumption of HCCtBu and exclusive production of Z-tBuCCCHCHtBu. From the 31P{1H} NMR spectrum generation of a new organometallic species was apparent (10, δ 25.0, 16.3; 2JPP = 364 Hz), accounting for 88% of the metal-containing species with 1 making up 10%. Addition of a further 50 equivalents of HCCtBu induced complete conversion of 1 into 10 within 24 h but coincided with a halt in homocoupling, which plateaued at 65 TONs.
Repeating the homocoupling reaction on a larger scale under similar conditions enabled isolation of 10 from solution in 76% yield, which was subsequently identified as iridium(III) bis(alkenyl) complex [Ir(PNP-14)(η3-E-C(CCtBu)CHtBu)(η1-E-CHCHtBu)][BArF4] (Scheme 4). In the solid state, 10 adopts a very distorted octahedral geometry with the alkenyl ligands in a cis configuration (C4–Ir1–C6 = 102.50(9)°) and coordination of the σ-organyl derived from Z-tBuCCCHCHtBu reinforced by π-complexation of the alkyne (Ir1–alkyne = 2.505(2) Å): a binding mode, for which there are no crystallographically characterised Group 9 precedents to our knowledge (CSD 5.41).34 The respective alkenyl Ir–C and CC bond lengths are not statistically different (Ir1–C4 = 2.043(2) Å, Ir1–C6 = 2.053(2) Å; C4–C5 = 1.330(3) Å, C6–C9 = 1.329(3) Å). The structure of 10 determined by X-ray crystallography was fully corroborated in solution using NMR spectroscopy. For instance, the alkenyl 1H resonances are located at δ 7.81 (IrCCHtBu; 3JHH = 15.0 Hz), 5.68 (IrCCtBu), and 4.78 (IrCHCtBu; 3JHH = 15.2 Hz) in a 1:1:1 ratio, with the associated 13C resonances at δ 143.5 (IrCHHtBu), 142.2 (IrCHtBu), 105.3 (IrCHtBu), and 95.7 (IrHCHtBu); the α-carbons exhibiting coupling to 31P (2JPC = 5–10 Hz). The HR-ESI MS of 10 is also notable for a strong [M]+ ion signal at 916.5623 (calcd 916.5628) m/z and bulk purity of was confirmed by combustion analysis.
Terminal alkyne homocoupling reactions that produce Z-enyne products are generally understood to proceed via vinylidene intermediates, with 11 implicated in this case (Scheme 4).35,36 Indeed, the rhodium homologue 11′ is produced initially upon reaction of 1′ with HCCtBu.15 Reaction with the second alkyne equivalent, by net 1,2-addition of the constituent C(sp)–H bond across the vinylidene MC linkage (concerted or step-wise) followed by reductive elimination, would thereafter confer the enyne product. E-Enyne isomers such as that observed in the rhodium system can also be produced in this manner, although an indirect route involving equilibrium generation of the rhodium(III) alkynyl hydride 12′ is instead invoked in the formation of 9′ from 11′ (Scheme 4). Whilst 11 was not detected during the formation of Z-tBuCCCHCHtBu, the generation of 10 provides strong circumstantial evidence for its intermediate presence. No reaction between 1 and independently synthesised Z-tBuCCCHCHtBu in DFB was observed, even upon heating at 50 °C for 1 h. The formation of the bis(alkenyl) is, therefore, most reasonably reconciled by irreversible reaction of Z-tBuCCCHCHtBu with 11; involving net 1,2-addition of the {CC}C(sp2)–H bond across the IrC linkage. The addition evidently takes place through the ring in this instance, with the macrocycle preventing subsequent reductive elimination.12 We therefore attribute the generation of 10 to catalyst deactivation by irreversible product inhibition. The postulated reactivity of the Group 9 vinylidenes derived from 1 and 1′ is clearly nuanced by the nature of the metal and impact of the unique steric constraints imposed by the tetradecamethylene linker. We believe that the more facile Ir(I)/Ir(III) redox couple and propensity of the {Ir(PNP-14)}+ fragment to adopt geometries with the pincer ligand in a non-meridional conformation are the decisive factors. Specifically, we propose that the Z-selective homocoupling of HCCtBu proceeds catalytically outside the ring via C(sp)–H bond oxidative addition of HCCtBu to 11 affording fac-[Ir(PNP-14)(CCHtBu)(CCtBu)H]+, alkynyl migration yielding an enynyl hydride, and finally release of Z-tBuCCCHCHtBu by reductive elimination. In contrast, 1′ mediates the stoichiometric E-selective homocoupling of HCCtBu through the ring ultimately via a pathway bypassing the vinylidene intermediate 11′. Further computational analysis would be required to corroborate these suggestions, although accurately modelling the effect of the methylene chain is non-trivial.
Onward reactivity of the {Ir(PNP-14)}+ fragment was also explored with the bulky unsaturated substrates 3,3-dimethylbutene and 3,3-dimethylbutyne. Reaction of 4 with 3,3-dimethylbutene induced triple C–H bond activation of the methylene chain yielding an iridium(III) allyl hydride complex [Ir(PNP-14*)H][BArF4] 7, whilst 1 is an effective pre-catalyst for the homocoupling of 3,3-dimethylbutyne into Z-tBuCCCHCHtBu under mild conditions. The latter is particularly remarkable given that reaction of the homologous rhodium precursor 1′ results in the formation of an interpenetrated E-enyne complex (9′). The mechanism of the homocoupling promoted by 1 is proposed to involve formation and direct reaction of the (unobserved) vinylidene derivative [Ir(PNP-14)(CCHtBu)][BArF4] (11) with HCCtBu outside of the macrocyclic ring. This suggestion is supported experimentally by isolation and crystallographic characterisation of [Ir(PNP-14)(η3-E-C(CCtBu)CHtBu)(η1-E-CHCHtBu)][BArF4] (10), which results from deactivation of the catalyst by product inhibition.
1 H NMR (500 MHz, DFB): δ 8.11–8.16 (m, 8H, ArF), 7.50 (br, 4H, ArF), 7.33 (t, 3JHH = 7.7, 1H, py), 7.08 (d, 3JHH = 7.7, 1H, py), 7.03 (obscured, py), 4.25–4.34 (m, 1H, Ir(CHCH){axial}), 4.34–4.44 (m, 1H, Ir(CHCH){axial}), 3.72 (d, 2JPH = 6.6, 2H, pyC2), 3.51 (dd, 2JHH = 18.2, 2JPH = 6.0, 1H, pyC2), 3.34 (dd, 2JHH = 18.2, 2JPH = 9.7, 1H, pyC2), 2.54–2.66 (m, 2H, CH2), 2.15–2.45 (m, 6H, CH2 + 1 × Ir(CHCH){equatorial} [δ 2.39]), 1.38–2.04 (m, 9H, CH2 + 1 × Ir(CHCH){equatorial} [δ 1.83]), 1.38 (d, 3JPH = 12.7, 9H, tBu), 0.94–1.32 (m, 19H, CH2), 0.65 (d, 3JPH = 12.5, 9H, tBu).
13 C{ 1 H} NMR (126 MHz, DFB): δ 163.7 (dd, JPC = 5, 4, py), 162.5 (q, 1JCB = 50, ArF), 162.4 (obscured, py), 138.2 (s, py), 135.1 (s, ArF), 129.7 (qq, 2JFC = 32, 3JCB = 3, ArF), 124.9 (q, 1JFC = 272, ArF), 122.0 (d, 3JPC = 6, py), 120.7 (d, 3JPC = 8, py), 117.6 (sept, 3JFC = 4, ArF), 64.7 (br, Ir(CHCH){axial}), 60.9 (d, 2JPC = 3, Ir(CHCH){axial}), 60.2 (dd, 2JPC = 27, 4, Ir(CHCH){equatorial}), 50.1 (dd, 2JPC = 29, 2JPC = 5, Ir(CHCH){equatorial}), 45.6 (dd, 1JPC = 27, 3JPC = 4, pyH2) 42.3 (d, 1JPC = 22, pyH2), 35.8 (d, 3JPC = 10, CH2), 35.5 (br, CH2), 35.2 (dd, 1JPC = 19, 3JPC = 4, tBu{C}), 34.1 (d, 1JPC = 7, PCH2), 33.4 (br, tBu{C}), 31.1 (d, 3JPC = 10, CH2), 29.8 (d, 3JPC = 9, CH2), 29.7 (s, CH2), 29.5 (s, CH2), 29.3 (d, 1JPC = 17, PCH2), 29.0 (s, CH2), 28.8 (s, CH2), 28.7 (s, CH2), 28.6 (br, CH2), 28.3 (s, CH2), 28.12 (s, CH2), 28.05 (s, CH2), 27.8 (d, 2JPC = 4, tBu{CH3}), 27.1 (d, 3JPC = 7, CH2), 27.0 (s, CH2), 26.6 (s, CH2), 26.4 (d, 2JPC = 5, tBu{CH3}).
31 P{ 1 H} NMR (162 MHz, DFB): δ 17.0 (s, 1P), 13.4 (s, 1P).
HR ESI-MS (positive ion 4 kV): 778.4221 ([M]+, calcd 778.4218) m/z.
Anal. calcd for C69H77BF24IrNP2 (1641.32 g mol−1): C, 50.49; H, 4.73; N, 0.85. Found: C, 50.40; H, 4.64; N, 0.87.
1 H NMR (500 MHz, CD2Cl2): δ 8.00 (t, 3JHH = 7.9, py, 1H), 7.70–7.76 (m, 10H, py + ArF), 7.64 (d, 3JHH = 7.6, 1H, biph), 7.60 (d, 3JHH = 7.5, 1H, biph), 7.56 (br, 4H, ArF), 7.39 (d, 3JHH = 7.6, 1H, biph), 7.19 (t, 3JHH = 7.3, 1H, biph), 7.10 (t, 3JHH = 7.5, 1H, biph), 6.88 (t, 3JHH = 7.4, 1H, biph), 6.33 (t, 3JHH = 7.8, 1H, biph), 5.35 (d, 3JHH = 8.2, 1H, biph), 4.02 (dd, 2JHH = 19.4, 2JPH = 9.6, 1H, pyC2), 3.75–3.89 (m, 2H, 2 × pyC2), 3.50 (dd, 3JHH = 17.0, 3JHH = 9.2, 1H, pyC2), 3.02–3.15 (m, 1H, PCH2), 2.78–2.88 (m, 1H, PCH2), 1.88–1.98 (m, 1H, CH2), 0.66–1.73 (m, 23H, CH2), 1.16 (d, 3JPH = 14.0, 9H, tBu), 0.49 (d, 3JPH = 16.1, 9H, tBu), 0.22–0.37 (m, 2H, CH2).
13 C{ 1 H} NMR (126 MHz, CD2Cl2): δ 164.6 (app t, JPC = 4, py), 163.3 (br, py), 162.3 (q, 1JCB = 50, ArF), 150.6 (d, 3JPC = 2 biph), 149.6 (s, biph), 145.3 (dd, 2JPC = 8, 6, biph{IrC}), 139.9 (s, py), 135.4 (s, ArF), 135.2 (s, biph), 129.42 (qq, 2JFC = 32, 3JCB = 3, ArF), 129.39 (s, biph), 126.3 (s, biph), 125.6 (s, biph), 125.3 (s, biph), 125.1 (q, 1JFC = 272, ArF), 123.5 (s, biph), 123.2 (d, 3JPC = 10, py), 123.1 (d, 3JPC = 9, py), 122.1 (s, biph), 121.3 (s, biph), 121.2 (app t, 2JPC = 6, biph{IrC}), 118.0 (sept, 3JFC = 4, ArF), 40.9 (d, 1JPC = 29, pyH2), 39.5 (d, 1JPC = 26, pyH2), 35.0 (d, 1JPC = 23, tBu{C}), 32.9 (d, 2JPC = 14, CH2), 32.8 (obscured, tBu{C}), 30.4 (s, CH2), 29.6 (s, CH2), 29.5 (s, CH2), 29.42 (s, CH2), 29.35 (s, CH2), 29.2 (s, CH2), 29.1 (d, 2JPC = 3, tBu{CH3}), 28.1 (s, CH2), 27.9 (d, 1JPC = 28, PCH2), 27.3 (s, CH2), 25.8 (br, CH2), 25.5 (s, tBu{CH3}), 24.7 (s, CH2), 24.1 (s, CH2), 19.7 (dd, 1JPC = 22, 3JPC = 3, PCH2).
31 P{ 1 H} NMR (162 MHz, CD2Cl2): δ 38.7 (d, 2JPP = 307, 1P), 20.9 (d, 2JPP = 307, 1P).
HR ESI-MS (positive ion, 4 kV): 822.3912 ([M]+, calcd 822.3906) m/z.
Anal. calcd for C73H73BF24IrNP2 (1685.33 g mol−1): C, 52.03; H, 4.37; N, 0.83; found: C, 51.88; H, 4.28; N, 0.81.
1 H NMR (400 MHz, DFB, H2, selected data): δ 7.61 (t, 3JHH = 7.8, 1H py), 3.66–3.82 (m, 2H, 2 × pyC2), 3.06 (dd, 2JHH = 17.3, 2JPH = 6.4, 1H, pyC2), 0.79 (d, 3JPH = 13.4, 9H, tBu), 0.67 (d, 3JPH = 14.1, 9H, tBu), −21.6 (app t, 2JPH = 15, 1H, IrH).
31 P{partial 1 H} NMR (162 MHz, DFB, H2): δ 40.6 (dd, 2JPP = 302, 2JPH = 14, 1P), 36.5 (dd, 2JPP = 302, 2JPH = 14, 1P).
1 H NMR (500 MHz, DFB, H2): δ 8.10–8.16 (m, 8H, ArF), 7.49 (br, 4H, ArF), 7.47 (t, 3JHH = 7.8, 1H, py), 7.19 (d, 3JHH = 7.8, 2H, py), 3.96 (dvt, 2JHH = 17.6, JPH = 8, 2H, pyC2), 3.12 (dvt, 2JHH = 17.6, JPH = 10, 2H, pyC2), 2.11–2.23 (m, 2H, PCH2), 1.12–1.69 (m, 26H, CH2), 0.91 (vt, JPH = 16, 18H, tBu), −9.27 (br, fwhm = 24 Hz, 4H, IrH4).
13 C{ 1 H} NMR (126 MHz, DFB, H2): δ 162.3 (q, 1JCB = 50, ArF), 162.4 (vt, JPC = 6, py), 138.9 (s, py), 135.1 (s, ArF), 129.7 (qq, 2JFC = 32, 3JCB = 3, ArF), 124.9 (q, 1JFC = 272, ArF), 120.4 (vt, JPC = 10, py), 117.6 (sept, 3JFC = 4, ArF), 44.4 (vt, JPC = 28, pyH2), 30.0 (vt, JPC = 32, tBu{C}), 29.0 (s, CH2), 28.9 (vt, JPC = 8, CH2), 28.3 (s, CH2), 28.2 (s, CH2), 27.5 (s, CH2), 26.3 (s, CH2), 25.8 (vt, JPC = 32, PCH2), 24.5 (vt, JPC = 6, tBu{CH3}).
31 P{ 1 H} NMR (162 MHz, DFB, H2,): δ 42.1 (s, 2P).
1 H NMR (600 MHz, DFB, Ar, 298 K, selected data): δ −9.26 (br, fwhm = 29 Hz, T1 = 88.8 ± 0.7 ms, 4H, IrH).
1 H NMR (600 MHz, DFB, Ar, 253 K, selected data): δ −9.27 (br, fwhm = 21 Hz, T1 = 50 ± 1, 4H, IrH).
1 H NMR (500 MHz, DFB, C2H4, selected data): δ 7.43 (t, 3JHH = 7.8, 1H, py), 3.71–3.84 (m, 2H, 2 × pyC2), 3.18–3.37 (m, 5H, 1 × pyC2 + 4 × C2H4), 3.08 (dd, 2JHH = 17.6, 2JPH = 10.4, 1H, pyC2), 0.89 (d, 3JPH = 14.9, 9H, tBu), 0.87 (d, 3JPH = 13.9, 9H, tBu), −7.89 (dd, 2JPH = 17.6, 2JPH = 13.1, 1H, IrH), −17.80 (app t, JPH = 11, 1H, IrH).
13 C{ 1 H} NMR (126 MHz, DFB, C2H4, selected data): δ 48.7 (s, C2H4).
31 P{ 1 H} NMR (162 MHz, DFB, C2H4): δ 33.4 (d, 2JPP = 314, 1P), 12.4 (d, 2JPP = 314, 1P).
1 H NMR (600 MHz, DFB, C2H4): δ 8.11–8.15 (m, 8H, ArF4), 7.50 (br, 4H, ArF4), 7.46 (t, 3JHH = 7.8, 1H, py), 7.15 (d, 3JHH = 7.8, 2H, py), 3.63 (dvt, 2JHH = 16.8, JPH = 8, 2H, pyC2), 3.28 (dvt, 2JHH = 16.8, JPH = 8, 2H, pyC2), 3.23 (br, 2H, C2H4), 2.80 (br, 2H, C2H4), 2.49 (br, 2H, C2H4), 1.97 (br, 2H, C2H4), 1.03–1.48 (m, 28H, CH2), 0.79 (br, 18H, tBu).
13 C{ 1 H} NMR (126 MHz, DFB, C2H4): δ 164.1 (d, 3JPC = 3, py), 162.6 (q, 1JCB = 50, ArF), 139.1 (s, py), 135.1 (s, ArF), 129.7 (qq, 2JFC = 32, 3JCB = 3, ArF), 124.9 (q, 1JFC = 272, ArF), 119.8 (vt, JPC = 8, py), 117.6 (sept, 3JFC = 4, ArF), 42.6 (vt, JPC = 28, pyH2), 33.5 (vt, JPC = 26, tBu{C}), 31.0 (s, CH2), 29.1 (vt, JPC = 12, CH2), 27.8 (s, CH2), 27.3 (s, CH2), 27.2 (s, CH2), 26.3 (s, tBu{CH3}), 26.0 (s, C2H4), 24.6 (s, CH2), 18.0 (s, C2H4), 14.3 (vt, JPC = 24, PCH2).
31 P{ 1 H} NMR (162 MHz, DFB, C2H4): δ 9.0 (s, 2P).
1 H NMR (500 MHz, CD2Cl2): δ 7.87 (t, 3JHH = 7.8, 1H, py), 7.70–7.76 (m, 8H, ArF), 7.56 (br, 4H, ArF), 7.51 (d, 3JHH = 7.9, 2H, py), 3.94 (dvt, 2JHH = 17.6, JPH = 8, 2H, pyC2), 3.47 (dvt, 2JHH = 17.6, JPH = 8, 2H, pyC2), 2.18–2.27 (m, 4H, PCH2), 1.94–2.07 (m, 2H, CH2), 1.76–1.89 (m, 2H, CH2), 1.64–1.74 (m, 2H, CH2), 1.54–1.64 (m, 2H, CH2), 1.23–1.48 (m, 16H, CH2), 1.14 (vt, JPH = 16, 18H, tBu)
13 C{ 1 H} NMR (126 MHz, CD2Cl2): δ 182.5 (vt, 2JPC = 18, CO), 165.4 (vt, JPC = 10, py), 162.3 (q, 1JCB = 50, ArF), 141.9 (s, py), 135.4 (s, ArF), 129.4 (qq, 2JFC = 32, 3JCB = 3, ArF), 125.2 (q, 1JFC = 272, ArF), 122.0 (vt, JPC = 10, py), 118.0 (sept, 3JFC = 4, ArF), 39.4 (vt, JPC = 24, pyH2), 34.7 (vt, JPC = 30, tBu{C}), 30.3 (vt, JPC = 10 CH2), 29.3 (s, CH2), 29.0 (s, CH2), 28.9 (s, CH2), 28.3 (s, CH2), 27.5 (vt, JPC = 6, tBu{CH3}), 26.1 (s, CH2), 23.4 (vt, JPC = 30, PCH2).
31 P{ 1 H} NMR (162 MHz, CD2Cl2): δ 64.6 (s, 2P).
31 P{ 1 H} NMR (162 MHz, DFB): δ 62.5 (s, 2P).
IR (CH2Cl2): ν(CO) 1984 cm−1.
HR ESI-MS (positive ion, 4 kV): 698.3217 ([M]+, calcd 698.3228) m/z.
Anal. calcd for C62H65BF24IrNOP2 (1561.14 g mol−1): C, 47.70; H, 4.20; N, 0.90; found: C, 47.89; H, 4.13; N, 0.97.
1 H NMR (400 MHz, CD2Cl2, selected data): δ 8.11–8.17 (m, 8H, ArF), 7.50 (s, 4H, ArF), 3.52 (vt, JPH = 8, 4H, pyC2), 1.11 (vt, JPH = 14, 36H, tBu), −9.48 (br, 4H, IrH).
31 P{ 1 H} NMR (162 MHz, DFB): δ 64.6 (s, 2P).
1 H NMR (500 MHz, CD2Cl2): δ 7.70–7.75 (m, 8H, ArF), 7.65 (t, 3JHH = 7.8, 1H, py), 7.56 (br, 4H, ArF), 7.34 (d, 3JHH = 7.8, 1H, py), 7.31 (d, 3JHH = 7.8, 1H, py), 4.86 (app q, JHH = 9, 1H, IrCH), 4.47 (app t, 3JHH = 7, 1H, IrCH), 3.71–3.81 (m, 2H, 2 × pyC2), 3.41 (dd, 2JHH = 17.1, 2JPH = 9.3, 1H, pyC2), 3.26 (dd, 2JHH = 17.4, 2JPH = 9.2, 1H, pyC2), 2.35–2.52 (m, 1H, CH2), 2.15–2.29 (m, 1H, CH2), 1.98–2.11 (m, 1H, CH2), 0.94–1.95 (m, 20H, IrCH [δ 1.89] + CH2), 1.17 (d, 3JPH = 15.4, 9H, tBu), 1.01 (d, 3JPH = 13.5, 9H, tBu), −8.49 (dd, 2JPH = 19.6, 9.7, 1H, IrH).
13 C{ 1 H} NMR (126 MHz, CD2Cl2): δ 163.4 (br, py), 162.3 (q, 1JCB = 50, ArF), 161.9 (br, py), 138.5 (s, py), 135.4 (s, ArF), 129.4 (qq, 2JFC = 32, 3JCB = 3, ArF), 125.1 (q, 1JFC = 272, ArF), 121.0 (d, 3JPC = 9, py), 120.8 (d, 3JPC = 9, py), 118.0 (sept, 3JFC = 4, ArF), 81.9 (s, IrCH), 66.0 (d, 2JPC = 5, IrCH), 41.9 (d, 1JPC = 30, pyH2), 39.2 (d, 1JPC = 29, pyH2), 38.9 (s, IrCH), 35.9 (s, CH2), 35.0 (dd, 1JPC = 22, 3JPC = 5, tBu{C}), 30.4 (dd, 1JPC = 22, 3JPC = 5, tBu{C}), 29.6 (s, CH2), 27.8 (d, 2JPC = 14, CH2), 27.4 (s, CH2), 27.0 (d, 2JPC = 3, tBu{CH3}), 25.7 (d, 2JPC = 4, tBu{CH3}), 24.8 (dd, 1JPC = 28, 3JPC = 1, PCH2), 24.4 (s, CH2), 24.3 (d, 2JPC = 5, CH2), 22.9 (s, CH2), 22.3 (s, CH2), 21.6 (s, CH2), 20.8 (dd, 1JPC = 24, 3JPC = 4, PCH2).
31 P{ 1 H} NMR (162 MHz, CD2Cl2): δ 81.4 (d, 2JPP = 313, 1P), 25.8 (d, 2JPP = 313, 1P).
31 P{ 1 H} NMR (162 MHz, DFB): δ 80.9 (d, 2JPP = 313, 1P), 25.5 (d, 2JPP = 313, 1P).
HR ESI-MS (positive ion 4 kV): 668.3128 ([M]+, calcd 668.3122) m/z.
Anal. calcd for C62H67BF24IrNP2 (1531.12 g mol−1): C, 47.85; H, 4.15; N, 0.91. Found: C, 47.65; H, 4.03; N, 1.01.
Data for Z-tBuCCCHCHtBu:1H NMR (400 MHz, DFB, selected data): δ 5.53 (d, 3JHH = 11.9, 1H, CHCH), 5.25 (d, 3JHH = 11.9, 1H, CHCH), 1.12 (s, 9H, tBu), 1.11 (s, 9H, tBu).
13 C{ 1 H} NMR (126 MHz, CD2Cl2): δ 164.2 (app t, JPC = 3, py), 163.3 (app t, JPC = 3, py), 162.3 (q, 1JCB = 50, ArF), 143.5 (app t, 3JPC = 4, IrCHHtBu), 142.2 (br, IrCHtBu), 139.4 (s, py), 135.4 (s, ArF), 129.4 (qq, 2JFC = 32, 3JCB = 3, ArF), 125.1 (q, 1JFC = 272, ArF), 121.7 (d, 3JPC = 8, py), 121.5 (d, 3JPC = 8, py), 118.0 (sept, 3JFC = 4, ArF), 116.9 (s, CtBu), 105.3 (dd, 2JPC = 8, 2JPC = 5, IrCHtBu), 95.7 (app t, 2JPC = 10, IrHCHtBu), 60.1 (s, CtBu), 46.0 (d, 1JPC = 25, pyH2), 40.8 (d, 1JPC = 30, pyH2), 37.3 (s, CHCHtBu{C}), 37.1 (s, CCHtBu{C}), 36.6 (dd, 1JPC = 21, 3JPC = 4, PtBu{C}), 34.6 (dd, 1JPC = 21, 3JPC = 6, PtBu{C}), 33.3 (d, 2JPC = 15, CH2), 32.2 (s, CH2), 31.8 (s, CCtBu{C}), 31.4 (s, CH2), 31.28 (s, tBu{CH3}), 31.26 (s, tBu{CH3}), 31.1 (s, CH2), 30.5 (s, CH2), 30.3 (s, CH2), 30.2 (s, CH2), 29.7 (s, CHCHtBu{CH3}), 28.8 (br, CH2), 28.20 (d, 2JPC = 4, CH2), 28.17 (s, CH2), 27.1 (d, 2JPC = 3, 2 × PtBu{CH3}), 26.6 (s, CH2), 24.9 (s, CH2), 21.9 (dd, 1JPC = 30, 3JPC = 2, PCH2), 19.5 (dd, 1JPC = 19, 3JPC = 3, PCH2).
31 P{ 1 H} NMR (162 MHz, CD2Cl2): δ 25.5 (d, 2JPP = 364, 1P), 16.8 (d, 2JPP = 364, 1P).
31 P{ 1 H} NMR (121 MHz, DFB): δ 25.0 (d, 2JPP = 364, 1P), 16.3 (d, 2JPP = 364, 1P).
HR ESI-MS (positive ion, 4 kV): 916.5623 ([M]+, calcd 916.5628) m/z.
Anal. calcd for C79H95BF24IrNP2 (1779.57 g mol−1): C, 53.35; H, 5.38; N, 0.79. Found: C, 53.26; H, 5.09; N, 0.77.
Footnote |
† Electronic supplementary information (ESI) available: Catalytic homocoupling of 3,3-dimethylbutyne promoted by 6, synthesis and characterisation of [Rh(PNP-14)(η2-norbornene)][BArF4]; NMR, IR and ESI-MS spectra of new compounds, and selected reactions (PDF). Primary NMR data (MNOVA). CCDC 2051203–2051207. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/d0dt04303f |
This journal is © The Royal Society of Chemistry 2021 |